Note! This is an old version of B&C site.
Biopolym. Cell. 2025; 41(4):283.
Molecular Biomedicine
Analysis for the association of polymorphic variants of the VDR gene(rs2228570) with the risk of herpetic keratitis occurrence after COVID-19
2Mohylevets A. O., 3Sereda E. V., 3Drozhzhyna G. I., 1Livshyts G. B., 1Gorodna O. V., 1Livshits L. A.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03143
  2. Educational and Scientific Center “Institute of Biology and Medicine” of Taras Shevchenko National University of Kyiv
    2, Akademika Hlushkova Ave., Kyiv, Ukraine, 03022
  3. SI “The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine”
    49/51, Frantsuz'ky Blvd, Odesa, Ukraine, 65000

Abstract

Aim. To investigate the association between polymorphic variants of the VDR gene rs2228570 and clinical features ofherpetic keratitis in adult patients who have had COVID-19. Methods. Peripheral blood samples from patients(N = 50) with a history of herpetic keratitis that developed after COVID-19 were studied. In comparison with (N = 104) unrelated healthy controls. DNA samples were isolated by lymphocyte lysis with proteinase K followed by the use of DNA purification kit (“MBA LABS”). Analysis of the VDR gene (rs2228570) was performed using fluorescently labeled TaqMan probes manufactured by Thermo Fisher Scientific (USA). Statistical analysis was performed using Fisher’s exact test. Results. The results of genotyping followed by comparative statistical analysis revealed significant differences in frequencies of both homozygous genotypes between patients with recurrent HK and controls (p = 0.01636). The GG genotype was significantly more common in the recurrent HK group. Importantly, the frequency of A allelecarriers (AA+GA) was statistically significantly higher in the control group (p < 0.05), OR=0.3381 with 95% CI(0.1433—0.797). Conclusions. It was shown that the G allele of the FokI VDR gene (rs2228570) polymorphism is associated with recurrent herpetic keratitis in patients from Ukraine, indicating it as a marker of hereditary predisposition to the development of recurrent herpetic keratitis after COVID-19.
Keywords: herpetic keratitis, COVID-19, genetic marker, VDR gene

References

[1] Chaloulis SK, Mousteris G, Tsaousis KT. Incidence and Risk Factors of Bilateral Herpetic Keratitis: 2022 Update. Trop Med Infect Dis. 2022; 7(6):92.
[2] Remeijer L, Maertzdorf J, Buitenwerf J, Osterhaus AD, Verjans GM. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis. Invest Ophthalmol Vis Sci. 2002; 43(2):358-63.
[3] Liesegang TJ. Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Arch Ophthalmol. 1989; 107(8):1160-5.
[4] Alkwikbi H, Alenazi M, Alanazi W, Alruwaili S. Herpetic Keratitis and Corneal Endothelitis Following COVID-19 Vaccination: A Case Series. Cureus. 2022; 14(1):e20967.
[5] Rallis KI, Fausto R, Ting DSJ, Al-Aqaba MA, Said DG, Dua HS. Manifestation of Herpetic Eye Disease after COVID-19 Vaccine: A UK Case Series. Ocul Immunol Inflamm. 2022; 30(5):1136-41.
[6] Lu X, Chen Z, Vick S, Watsky MA. Vitamin D receptor and metabolite effects on corneal epithelial cell gap junction proteins. Exp Eye Res. 2019; 187:107776.
[7] Szpirer J, Szpirer C, Riviere M, Levan G, Marynen P, Cassiman JJ, Wiese R, DeLuca HF. The Sp1 transcription factor gene (SP1) and the 1,25-dihydroxyvitamin D3 receptor gene (VDR) are colocalized on human chromosome arm 12q and rat chromosome 7. Genomics. 1991; 11(1):168-73.
[8] Miyamoto K, Kesterson RA, Yamamoto H, Taketani Y, Nishiwaki E, Tatsumi S, Inoue Y, Morita K, Takeda E, Pike JW. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol. 1997; 11(8):1165-79.
[9] Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983; 57(6):1308-10.
[10] Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983; 221(4616):1181-3.
[11] Kreutz M, Andreesen R, Krause SW, Szabo A, Ritz E, Reichel H. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood. 1993; 82(4):1300-7.
[12] Brennan A, Katz DR, Nunn JD, Barker S, Hewison M, Fraher LJ, O'Riordan JL. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology. 1987; 61(4):457-61.
[13] Yu S, Cantorna MT. The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci U S A. 2008; 105(13):5207-12.
[14] Arora J, Wang J, Weaver V, Zhang Y, Cantorna MT. Novel insight into the role of the vitamin D receptor in the development and function of the immune system. J Steroid Biochem Mol Biol. 2022; 219:106084.
[15] Gussago C, Arosio B, Guerini FR, Ferri E, Costa AS, Casati M, Bollini EM, Ronchetti F, Colombo E, Bernardelli G, Clerici M, Mari D. Impact of vitamin D receptor polymorphisms in centenarians. Endocrine. 2016; 53(2):558-64.
[16] Obukhova OA, Ataman AV, Zavadska MM, Piven SM, Levchenko ZM. The association of vitamin D receptor gene (VDR) polymorphisms with high blood pressure in stroke patients of Ukrainian population. Wiad Lek. 2020; 73(11):2349-53.
[17] Laplana M, Royo JL, Fibla J. Vitamin D Receptor polymorphisms and risk of enveloped virus infection: A meta-analysis. Gene. 2018; 678:384-94.
[18] He Q, Huang Y, Zhang L, Yan Y, Liu J, Song X, Chen W. Association between vitamin D receptor polymorphisms and hepatitis B virus infection susceptibility: A meta-analysis study. Gene. 2018; 645:105-12.
[19] Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Thaimai P, Wasitthankasem R, Poovorawan Y, Komolmit P. Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C. PeerJ. 2019; 7:e7666.
[20] Drozhzhyna GI, Sereda KV, Khramenko NI. Features of the course of post-COVID-19 primary and recurrent herpetic keratitis. J Ophthalmol. 2024; 6:3-9.
[21] Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res. 1996; 6(10):995-1001.
[22] Van der Velden VHJ, Szczepański T, van Dongen JJM. Real-time quantitative PCR. Rev Mol Genet. 2002; 3(1):77-83.
[23] Doost ME, Hong J, Broatch JE, Applegate MT, Wagner CE, Marshall PA, Jurutka PW. Synergistic Activation of VDR-RXR Heterodimers by Vitamin D and Rexinoids in Human Kidney and Brain Cells. Cells. 2024; 13(22):1878.
[24] Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2):143-56.
[25] Fan NW, Dohlman TH, Foulsham W, McSoley M, Singh RB, Chen Y, Dana R. The role of Th17 immunity in chronic ocular surface disorders. Ocul Surf. 2021; 19:157-68.
[26] Ruiz-Ballesteros AI, Meza-Meza MR, Vizmanos-Lamotte B, Parra-Rojas I, de la Cruz-Mosso U. Association of Vitamin D Metabolism Gene Polymorphisms with Autoimmunity: Evidence in Population Genetic Studies. Int J Mol Sci. 2020; 21(24):9626.
[27] Hitchon CA, Sun Y, Robinson DB, Peschken CA, Bernstein CN, Siminovitch KA, El-Gabalawy HS. Vitamin D receptor polymorphism rs2228570 (Fok1) is associated with rheumatoid arthritis in North American natives. J Rheumatol. 2012; 39(9):1792-7.
[28] Karray EF, Ben Dhifallah I, Ben Abdelghani K, Ben Ghorbel I, Khanfir M, Houman H, Hamzaoui K, Zakraoui L. Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behçet's disease in Tunisians. Joint Bone Spine. 2012; 79(2):144-8.
[29] Maalej A, Petit-Teixeira E, Michou L, Rebai A, Cornelis F, Ayadi H. Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immun. 2005; 6(8):707-11.
[30] Song GG, Bae SC, Lee YH. Vitamin D receptor FokI, BsmI, and TaqI polymorphisms and susceptibility to rheumatoid arthritis : A meta-analysis. Z Rheumatol. 2016; 75(3):322-9.
[31] Tizaoui K, Hamzaoui K. Association between VDR polymorphisms and rheumatoid arthritis disease: Systematic review and updated meta-analysis of case-control studies. Immunobiology. 2015; 220(6):807-16.
[32] Cauci S, Migliozzi F, Trombetta CS, Venuto I, Saccheri P, Travan L, Chiriacò G. Low back pain and FokI (rs2228570) polymorphism of vitamin D receptor in athletes. BMC Sports Sci Med Rehabil. 2017; 9:4.